Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Confirmation Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

NCT00386815 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00386815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00386815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Confirmation Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
February 28, 2007
Enrollment
20
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma